Literature DB >> 15671789

Diabetes care management participation in a primary care setting and subsequent hospitalization risk.

Anthony J Greisinger1, Rajesh Balkrishnan, Rahul A Shenolikar, Oscar A Wehmanen, Shahid Muhammad, P Kay Champion.   

Abstract

Scant evidence exists that examines the impact of participation in primary care diabetes management programs and their educational components on the risk of subsequent significant patient morbidity. This study examined the association between participation in a diabetes management program in a primary care setting and the risk of subsequent hospitalization. Ten thousand nine hundred eighty patients with diabetes mellitus receiving some type of treatment in a large primary care clinic network in Houston, TX were examined for incidence of hospitalization in the year 2002. Information from the year preceding the hospitalization was obtained on several demographic, clinical, and diabetes care management participation related variables. Multivariate logistic regressions were used to examine the relationship between primary care diabetes management participation as well as individual educational components and the likelihood of subsequent-year hospitalization. Patients participating in some type of primary care diabetes management were 16% less likely to have an incidence of hospitalization (p = 0.05). When individual educational components of the diabetes care management program were examined, diabetes education sessions were more beneficial than certified diabetes educator visits in reducing the incidence of hospitalization. Patients with controlled blood glucose levels and a diabetes education session seemed to have the most significant reduction in hospitalization risk (odds ratio [OR] = 0.62; 95% CI: 0.40, 0.95). There seem to be beneficial effects associated with participation in primary care diabetes management programs in terms of reduced hospitalization risk. Attendance at diabetes educational sessions in primary care settings coupled with maintenance of blood glucose control seem to be associated with greatest risk reduction.

Entities:  

Mesh:

Year:  2004        PMID: 15671789     DOI: 10.1089/dis.2004.7.325

Source DB:  PubMed          Journal:  Dis Manag        ISSN: 1093-507X


  6 in total

1.  Limited options: a report on GP access to services.

Authors:  A Ní Shúilleabháin; M O'Kelly; F O'Kelly; T O'Dowd
Journal:  Ir J Med Sci       Date:  2007-03       Impact factor: 1.568

2.  Impact of a Telephonic Intervention to Improve Diabetes Control on Health Care Utilization and Cost for Adults in South Bronx, New York.

Authors:  Bahman P Tabaei; Renata E Howland; Jeffrey S Gonzalez; Shadi Chamany; Elizabeth A Walker; Clyde B Schechter; Winfred Y Wu
Journal:  Diabetes Care       Date:  2020-03-04       Impact factor: 19.112

3.  Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study.

Authors:  Jessica M Robbins; Gail E Thatcher; David A Webb; Vivian G Valdmanis
Journal:  Diabetes Care       Date:  2008-01-09       Impact factor: 19.112

4.  Defining High Value Elements for Reducing Cost and Utilization in Patient-Centered Medical Homes for the TOPMED Trial.

Authors:  Tracy Marie Anastas; Jesse Wagner; Rachel Lauren Ross; Bhavaya Sachdeva; LeAnn Michaels; Kimberley Gray; Katie Cartwright; David A Dorr
Journal:  EGEMS (Wash DC)       Date:  2019-05-03

5.  Patterns of engagement with the health care system and risk of subsequent hospitalization amongst patients with diabetes.

Authors:  Paul E Ronksley; Pietro Ravani; Claudia Sanmartin; Hude Quan; Braden Manns; Marcello Tonelli; Brenda R Hemmelgarn
Journal:  BMC Health Serv Res       Date:  2013-10-09       Impact factor: 2.655

6.  Role of Interprofessional primary care teams in preventing avoidable hospitalizations and hospital readmissions in Ontario, Canada: a retrospective cohort study.

Authors:  Wissam Haj-Ali; Rahim Moineddin; Brian Hutchison; Walter P Wodchis; Richard H Glazier
Journal:  BMC Health Serv Res       Date:  2020-08-24       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.